100
NPS Score
VS
Homology Medicines
- EMPLOYEE
PARTICIPANTS - 0
- TOTAL
RATINGS
Spark Therapeutics
- EMPLOYEE
PARTICIPANTS - 14
- TOTAL
RATINGS
Homology Medicines vs Spark Therapeutics
Competitors at Homology Medicines is not yet available. Get insights into the competitive rankings of Homology Medicines CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
Homology Medicines
Homology Medicines's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Homology Medicines. Their current valuation is $57.22M.
Spark Therapeutics
Spark Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Spark Therapeutics. Their current market cap is $4.29B.
4/5
Product Quality
3.7/5
5/5
Pricing
5/5
5/5
Customer Service
5/5
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
See how Homology Medicines compares to its competitors
See how Spark Therapeutics compares to its competitors
Working at Homology Medicines vs Working at Spark Therapeutics
Not enough ratings
CEO Rating
68 / 100
CEO Rating
Winner
Homology Medicines
Homology Medicines doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Spark Therapeutics
Employees at Spark Therapeutics rate their CEO, Jeffrey Marrazzo, 68/100.